Literature DB >> 15134136

Phospholipids and oxophospholipids in atherosclerotic plaques at different stages of plaque development.

Amir Ravandi1, Saeid Babaei, Ramsey Leung, Juan Carlos Monge, George Hoppe, Henry Hoff, Hiroshi Kamido, Arnis Kuksis.   

Abstract

We identified and quantified the hydroperoxides, hydroxides, epoxides, isoprostanes, and core aldehydes of the major phospholipids as the main components of the oxophospholipids (a total of 5-25 pmol/micromol phosphatidylcholine) in a comparative study of human atheroma from selected stages of lesion development. The developmental stages examined included fatty streak, fibrous plaque, necrotic core, and calcified tissue. The lipid analyses were performed by normal-phase HPLC with on-line electrospray MS using conventional total lipid extracts. There was great variability in the proportions of the various oxidation products and a lack of a general trend. Specifically, the early oxidation products (hydroperoxides and epoxides) of the glycerophosphocholines were found at the advanced stages of the plaques in nearly the same relative abundance as the more advanced oxidation products (core aldehydes and acids). The anticipated linear accumulation of the more stable oxidation products with progressive development of the atherosclerotic plaque was not apparent. It is therefore suggested that lipid infiltration and/or local peroxidation is a continuous process characterized by the formation and destruction of both early and advanced products of lipid oxidation at all times. The process of lipid deposition appears to have been subject to both enzymatic and chemical modification of the normal tissue lipids. Clearly, the appearance of new and disproportionate old lipid species excludes randomness in any accumulation of oxidized LDL lipids in atheroma.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15134136     DOI: 10.1007/s11745-004-1207-5

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  58 in total

1.  Apolipoprotein A-I promotes the formation of phosphatidylcholine core aldehydes that are hydrolyzed by paraoxonase (PON-1) during high density lipoprotein oxidation with a peroxynitrite donor.

Authors:  Z Ahmed; A Ravandi; G F Maguire; A Emili; D Draganov; B N La Du; A Kuksis; P W Connelly
Journal:  J Biol Chem       Date:  2001-04-24       Impact factor: 5.157

2.  Evidence for lipid peroxidation in atherosclerosis.

Authors:  J J Piotrowski; G C Hunter; C D Eskelson; M A Dubick; V M Bernhard
Journal:  Life Sci       Date:  1990       Impact factor: 5.037

3.  Core aldehydes of alkyl glycerophosphocholines in atheroma induce platelet aggregation and inhibit endothelium-dependent arterial relaxation.

Authors:  Hiroshi Kamido; Hiroyuki Eguchi; Hisao Ikeda; Tsutomu Imaizumi; Kazunari Yamana; Karsten Hartvigsen; Amir Ravandi; Arnis Kuksis
Journal:  J Lipid Res       Date:  2002-01       Impact factor: 5.922

4.  Glucosylated glycerophosphoethanolamines are the major LDL glycation products and increase LDL susceptibility to oxidation: evidence of their presence in atherosclerotic lesions.

Authors:  A Ravandi; A Kuksis; N A Shaikh
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-02       Impact factor: 8.311

5.  Oxidized phospholipids, linked to apolipoprotein B of oxidized LDL, are ligands for macrophage scavenger receptors.

Authors:  K L Gillotte; S Hörkkö; J L Witztum; D Steinberg
Journal:  J Lipid Res       Date:  2000-05       Impact factor: 5.922

6.  Oxidized cholesteryl linoleates stimulate endothelial cells to bind monocytes via the extracellular signal-regulated kinase 1/2 pathway.

Authors:  Joakim Huber; Herbert Boechzelt; Barbara Karten; Michael Surboeck; Valery N Bochkov; Bernd R Binder; Wolfgang Sattler; Norbert Leitinger
Journal:  Arterioscler Thromb Vasc Biol       Date:  2002-04-01       Impact factor: 8.311

Review 7.  Immunological responses to oxidized LDL.

Authors:  S Hörkkö; C J Binder; P X Shaw; M K Chang; G Silverman; W Palinski; J L Witztum
Journal:  Free Radic Biol Med       Date:  2000-06-15       Impact factor: 7.376

8.  Fatty acid oxidation products in human atherosclerotic plaque: an analysis of clinical and histopathological correlates.

Authors:  Emma I Waddington; Kevin D Croft; Kishore Sienuarine; Bruce Latham; Ian B Puddey
Journal:  Atherosclerosis       Date:  2003-03       Impact factor: 5.162

9.  The relationship of hydroxyeicosatetraenoic acids and F2-isoprostanes to plaque instability in human carotid atherosclerosis.

Authors:  Z Mallat; T Nakamura; J Ohan; G Lesèche; A Tedgui; J Maclouf; R C Murphy
Journal:  J Clin Invest       Date:  1999-02       Impact factor: 14.808

10.  Mature human atherosclerotic plaque contains peroxidized phosphatidylcholine as a major lipid peroxide.

Authors:  J J Piotrowski; S Shah; J J Alexander
Journal:  Life Sci       Date:  1996       Impact factor: 5.037

View more
  17 in total

1.  Alpha linolenic acid decreases apoptosis and oxidized phospholipids in cardiomyocytes during ischemia/reperfusion.

Authors:  Riya Ganguly; Devin Hasanally; Aleksandra Stamenkovic; Thane G Maddaford; Rakesh Chaudhary; Grant N Pierce; Amir Ravandi
Journal:  Mol Cell Biochem       Date:  2017-06-20       Impact factor: 3.396

Review 2.  Oxidative lipidomics coming of age: advances in analysis of oxidized phospholipids in physiology and pathology.

Authors:  Corinne M Spickett; Andrew R Pitt
Journal:  Antioxid Redox Signal       Date:  2015-03-26       Impact factor: 8.401

3.  Detection of potential new biomarkers of atherosclerosis by probe electrospray ionization mass spectrometry.

Authors:  Hisashi Johno; Kentaro Yoshimura; Yuki Mori; Tokuhide Kimura; Manabu Niimi; Masaki Yamada; Tetsuo Tanigawa; Jianglin Fan; Sen Takeda
Journal:  Metabolomics       Date:  2018-02-27       Impact factor: 4.290

4.  1 -O-alkyl-2-(omega-oxo)acyl-sn-glycerols from shark oil and human milk fat are potential precursors of PAF mimics and GHB.

Authors:  Karsten Hartvigsen; Amir Ravandi; Richard Harkewicz; Hiroshi Kamido; Klaus Bukhave; Gunhild Hølmera; Arnis Kuksis
Journal:  Lipids       Date:  2006-07       Impact factor: 1.880

5.  Release and capture of bioactive oxidized phospholipids and oxidized cholesteryl esters during percutaneous coronary and peripheral arterial interventions in humans.

Authors:  Amir Ravandi; Gregor Leibundgut; Ming-Yow Hung; Mitul Patel; Patrick M Hutchins; Robert C Murphy; Anand Prasad; Ehtisham Mahmud; Yury I Miller; Edward A Dennis; Joseph L Witztum; Sotirios Tsimikas
Journal:  J Am Coll Cardiol       Date:  2014-03-05       Impact factor: 24.094

6.  Hydrolysis of Phosphatidylcholine-Isoprostanes (PtdCho-IP) by Peripheral Human Group IIA, V and X Secretory Phospholipases A2 (sPLA2).

Authors:  Arnis Kuksis; Waldemar Pruzanski
Journal:  Lipids       Date:  2017-05-20       Impact factor: 1.880

7.  Substrate specificity and catalytic efficiency of aldo-keto reductases with phospholipid aldehydes.

Authors:  Matthew Spite; Shahid P Baba; Yonis Ahmed; Oleg A Barski; Kanchan Nijhawan; J Mark Petrash; Aruni Bhatnagar; Sanjay Srivastava
Journal:  Biochem J       Date:  2007-07-01       Impact factor: 3.857

8.  A comparison of five lipid extraction solvent systems for lipidomic studies of human LDL.

Authors:  Ana Reis; Alisa Rudnitskaya; Gavin J Blackburn; Norsyahida Mohd Fauzi; Andrew R Pitt; Corinne M Spickett
Journal:  J Lipid Res       Date:  2013-05-13       Impact factor: 5.922

9.  Cytotoxic phospholipid oxidation products. Cell death from mitochondrial damage and the intrinsic caspase cascade.

Authors:  Rui Chen; Lili Yang; Thomas M McIntyre
Journal:  J Biol Chem       Date:  2007-06-27       Impact factor: 5.157

10.  Inhaled diesel emissions alter atherosclerotic plaque composition in ApoE(-/-) mice.

Authors:  Matthew J Campen; Amie K Lund; Travis L Knuckles; Daniel J Conklin; Barbara Bishop; David Young; Steven Seilkop; JeanClare Seagrave; Matthew D Reed; Jacob D McDonald
Journal:  Toxicol Appl Pharmacol       Date:  2009-11-03       Impact factor: 4.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.